-
Aenova Expands Capacity for Fill & Finish of Vaccines and Biologics
contractpharma
May 08, 2021
New €16M area for sterile production including vaccine fill and finish is being built at the Aenova site in Latina, Italy.
-
Kemwell Biopharma increases capacity for manufacturing of biologics
expresspharma
April 28, 2021
The company has acquired an Ambr 250, added three single use bioreactors (SUBs) to support process scale-up, preclinical toxicology batch and early cGMP clinical trial supplies at 250L to 1000L scale in its current facility.
-
Biologics CDMO market to double in value by 2026, suggests report
europeanpharmaceuticalreview
April 16, 2021
Research suggests the increasing R&D investment in and adoption of biologics will drive growth in the global biologics contract development and manufacturing organisation (CDMO) market.
-
Cytovance Biologics Offers Licensing for Plasmid DNA Manufacturing
contractpharma
March 10, 2021
The Keystone Expression System pDNA platform is an end-to-end solution for manufacturing GMP pDNA at scale.
-
Wacker Strengthens Biologics Business
contractpharma
February 05, 2021
The Munich, Gemany-based chemical company Wacker is acquiring 100 percent of the shares in pharmaceutical contract manufacturer Genopis from South Korea-based firms Helixmith and Medivate Partners.
-
Almac Expands Global Biologics Testing Services
contractpharma
January 28, 2021
Almac Sciences, a member of the Almac Group, has expanded its biologics testing laboratory with significant investment in mass spectrometry equipment.
-
Charles River Partners with JADE
contractpharma
January 15, 2021
Charles River Laboratories International Inc. has entered into a strategic partnership with JADE Biomedical (JADE), a provider of end-to-end quality management services for the biopharmaceutical industry.
-
Cytiva delivers modular biologics factory to Lonza
prnasia
January 14, 2021
Cytiva, a global life sciences leader, has successfully completed another KUBio installation, this time to global healthcare solutions provider Lonza, in Guangzhou Biopark, China.
-
Abzena Unveils New Biologics GMP Manufacturing Site
contractpharma
January 12, 2021
Abzena, a global partner research organization for integrated bench to market solutions for biologics and bioconjugates, has added a sixth global site that will augment cGMP manufacturing capacity for mammalian biologics.
-
CDMO Stelis Continues Expansion
contractpharma
December 02, 2020
Contract development and manufacturing organization (CDMO), Stelis BioSource, a division of Stelis Biopharma Pvt. Ltd., has started the next phase of its continued investment program after having already invested well over $100 million into its ...